GFB-204

N/A

Report date: 2025/06/11 10:22:06
NME

Base Information

Drug NameGFB-204
Drug Alias NameGFB-204OCR-1642
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor receptor antagonistsPlatelet-derived growth factor receptor inhibitors +[4] 
TargetsVascular endothelial growth factor receptorPlatelet-derived growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of South Florida
China Registration ClassN/A

Develop Information

Active CompaniesYale University
Inactive CompaniesKirax CorpUniversity Of South Florida
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A